Author:
Falade Catherine,Makanga Michael,Premji Zul,Ortmann Christine-Elke,Stockmeyer Marlies,de Palacios Patricia Ibarra
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Medicine,Parasitology
Reference23 articles.
1. An integrated assessment of the clinical safety of artemether–lumefantrine: a new oral fixed-dose combination antimalarial drug;Bakshi;Trans. R. Soc. Trop. Med. Hyg.,2000
2. Cardiac effects of co-artemether (artemether/lumefantrine) and mefloquine given alone or in combination to healthy volunteers;Bindschedler;Eur. J. Clin. Pharmacol.,2000
3. Clinical trial of artesunate and artemether on multidrug resistant falciparum malaria in Thailand. A preliminary report;Bunnag;Southeast Asian J. Trop. Med. Public Health,1991
4. Committee for Proprietary Medicinal Products, 1997. Points to consider: the assessment of the potential for QT interval prolongation by non-cardiovascular medicinal products. London, EMEA, CPMP/986/86.
5. Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients;Ezzet;Br. J. Clin. Pharmacol.,1998
Cited by
126 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献